Skip to Content
Merck
CN
  • Preparation and characterization of a human scFv against the Clostridium perfringens type A alpha-toxin.

Preparation and characterization of a human scFv against the Clostridium perfringens type A alpha-toxin.

Toxicon : official journal of the International Society on Toxinology (2017-03-06)
Dongdong Wang, Yuhuan Yue, Guangmou Wu, Yuan Tian, Yuling Liu, Jia Yu, Yuangang Ji, Jinpeng Wang, Jian Li, Rongrong Pan, Hongyuan Ma, Guoli Zhang
ABSTRACT

Alpha-toxin produced by Clostridium perfringens is an important virulence factor, causing food poisoning and gas gangrene in humans. As such, it is considered a potential bioterrorism threat. To date, there is still no human effective therapeutic drug against alpha-toxin. In this study, a human single chain antibody against alpha-toxin was produced from synthetic (Tomlinson I + J) naive phage display libraries, and its preventive and therapeutic efficacy in mice was examined. To prove the neutralizing potential of the scFv, alpha-toxin was preincubated with scFv and subsequently tested for its lecithinase and hemolytic activity, as well as its lethal effect in mice following intravenous administration. The equilibrium association constant between scFv and CPA was 2.02 × 10

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N6-Cyclopentyladenosine, solid